Annual Drug Patent Expirations for WYNZORA
Wynzora is a drug marketed by MC2 and is included in one NDA. It is available from one supplier. There are two patents protecting this drug.
This drug has thirty-eight patent family members in twenty-seven countries.
The generic ingredient in WYNZORA is betamethasone dipropionate; calcipotriene. One supplier is listed for this compound. Additional details are available on the betamethasone dipropionate; calcipotriene profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
